Skip to main content

HOLLENCREST CAPITAL MANAGEMENT

Position in CRSP — CRISPR Therapeutics AG

CIK 1161722 NEWPORT BEACH, CA

Position in CRSP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$20,452
-$41,959 QoQ
Shares Held
375
-71.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#373
of 512 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRSP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HOLLENCREST CAPITAL MANAGEMENT holds $1,718,963 across 26 Biotechnology names. CRSP ranks #8 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 CRSP
CRISPR Therapeutics AG
This page
375 $20,452

All Filings in CRSP

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,452 375
2026-03-31 $62,411 1,312
2025-12-31 $19,665 375
2025-09-30 $40,506 625
2025-06-30 $30,400 625
2025-03-31 $21,268 625
2024-12-31 $24,600 625
2024-09-30 $29,362 625
2024-06-30 $33,756 625
2024-03-31 $42,600 625
2023-12-31 $39,125 625
2023-09-30 $28,368 625
2023-06-30 $35,087 625
2023-03-31 $28,268 625
2022-12-31 $25,406 625